Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

M Annala; G Lo; R Aggarwal; EJ Small; M Nykter; ME Gleave; KN Chi; AW Wyatt; WJ Struss; EW Warner; K Beja; G Vandekerkhove; A Wong; D Khalaf; IL Seppälä; A So

doi:10.1016/j.eururo.2017.02.023

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

M Annala
, G Lo
, R Aggarwal
, EJ Small
, M Nykter
, ME Gleave
, KN Chi
, AW Wyatt
, WJ Struss
, EW Warner
, K Beja
, G Vandekerkhove
, A Wong
, D Khalaf
, IL Seppälä
, A So

Research output: Contribution to journal › Article › Scientific › peer-review

199 Citations (Scopus)

Original language	English
Pages (from-to)	34-42
Journal	European Urology
Volume	72
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2017.02.023
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Abiraterone
BRCA2
Castration-resistant prostate cancer
Cell-free DNA
Circulating tumor DNA
DNA repair
Enzalutamide
Liquid biopsy

Publication forum classification

Publication forum level 3

Access to Document

10.1016/j.eururo.2017.02.023

Cite this

Annala, M., Lo, G., Aggarwal, R., Small, EJ., Nykter, M., Gleave, ME., Chi, KN., Wyatt, AW., Struss, WJ., Warner, EW., Beja, K., Vandekerkhove, G., Wong, A., Khalaf, D., Seppälä, IL., & So, A. (2017). Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer. European Urology, 72(1), 34-42. https://doi.org/10.1016/j.eururo.2017.02.023

@article{40fbda59f3c3453da2e7bc5d3d12887e,

title = "Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer",

keywords = "Abiraterone, BRCA2, Castration-resistant prostate cancer, Cell-free DNA, Circulating tumor DNA, DNA repair, Enzalutamide, Liquid biopsy, Abiraterone, BRCA2, Castration-resistant prostate cancer, Cell-free DNA, Circulating tumor DNA, DNA repair, Enzalutamide, Liquid biopsy",

author = "M Annala and G Lo and R Aggarwal and EJ Small and M Nykter and ME Gleave and KN Chi and AW Wyatt and WJ Struss and EW Warner and K Beja and G Vandekerkhove and A Wong and D Khalaf and IL Sepp{\"a}l{\"a} and A So",

year = "2017",

doi = "10.1016/j.eururo.2017.02.023",

language = "English",

volume = "72",

pages = "34--42",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

Annala, M, Lo, G, Aggarwal, R, Small, EJ, Nykter, M, Gleave, ME, Chi, KN, Wyatt, AW, Struss, WJ, Warner, EW, Beja, K, Vandekerkhove, G, Wong, A, Khalaf, D, Seppälä, IL & So, A 2017, 'Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer', European Urology, vol. 72, no. 1, pp. 34-42. https://doi.org/10.1016/j.eururo.2017.02.023

TY - JOUR

T1 - Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

AU - Annala, M

AU - Lo, G

AU - Aggarwal, R

AU - Small, EJ

AU - Nykter, M

AU - Gleave, ME

AU - Chi, KN

AU - Wyatt, AW

AU - Struss, WJ

AU - Warner, EW

AU - Beja, K

AU - Vandekerkhove, G

AU - Wong, A

AU - Khalaf, D

AU - Seppälä, IL

AU - So, A

PY - 2017

Y1 - 2017

KW - Abiraterone

KW - BRCA2

KW - Castration-resistant prostate cancer

KW - Cell-free DNA

KW - Circulating tumor DNA

KW - DNA repair

KW - Enzalutamide

KW - Liquid biopsy

KW - Abiraterone

KW - BRCA2

KW - Castration-resistant prostate cancer

KW - Cell-free DNA

KW - Circulating tumor DNA

KW - DNA repair

KW - Enzalutamide

KW - Liquid biopsy

U2 - 10.1016/j.eururo.2017.02.023

DO - 10.1016/j.eururo.2017.02.023

M3 - Article

SN - 0302-2838

VL - 72

SP - 34

EP - 42

JO - European Urology

JF - European Urology

IS - 1

ER -